Last edition
News about Global Pharma
Intrinsic Therapeutics Appoints Keith Valentine as President and Chief Executive Officer
Intrinsic Therapeutics, announced the appointment of Keith Valentine as President and Chief Executive Officer. Valentine will also join the Board of Directors and will begin his role in early May.
Global Pharma | 11/04/2025 | By Manvi | 365
Akums Drugs & Pharmaceuticals Ltd. has installed a 600 kWp rooftop solar power plant at its warehouse in Haridwar, Uttarakhand marking a major step in its commitment to sustainability and clean energy adoption.
Global Pharma | 11/04/2025 | By Manvi | 826
Innoblative Wins FDA IDE Approval for SIRA Device, Advancing Breast Cancer Surgery Innovation
Innoblative's SIRA device is a single-use, disposable applicator built for intraoperative ablation of the post-lumpectomy cavity during breast conserving surgery.
Global Pharma | 11/04/2025 | By Abha | 681
Novartis Unveils USD 23 Billion US Investment to Boost Domestic Drug Manufacturing and Research
Over the next 5 years, Novartis will establish 1 biomedical research innovation hub in San Diego, CA, its second global R&D hub in the US.
Global Pharma | 11/04/2025 | By Abha | 846
Biocon Biologics Announces USFDA Approval of JOBEVNE Biosimilar for Cancer Treatment
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd announced that the US Food and Drug Administration (USFDA) has approved Jobevne™ (bevacizumab-nwgd), a biosimilar Bevacizumab for intravenous use.
Global Pharma | 10/04/2025 | By Manvi | 576
OneSource Specialty Pharma’s flagship Unit 2 facility in Bengaluru has received GMP certification from Brazil's ANVISA, enabling it to supply high-quality biologics and drug-device combinations to the Brazilian market.
Global Pharma | 10/04/2025 | By Manvi | 463
Eko Health Launches CORE 500 Digital Stethoscope and Eko+ Membership in Canada
Eko Health announced the launch of the CORE 500™ Digital Stethoscope and Eko+ Membership in Canada. This expansion follows Health Canada approval of the CORE 500 Digital Stethoscope and Eko+, making it available to Canadian clinicians seeking advanced digital auscultation technology to support cardiac and pulmonary care.
Global Pharma | 10/04/2025 | By Manvi | 740
The collaboration aims to develop mucosal vaccines by combining Orexo's powder-based drug delivery technology AmorphOX with Abera's innovative and patented vaccine platform BERA™.
Global Pharma | 10/04/2025 | By Abha | 396
B. Braun Medical Receives FDA Approval for Piperacillin, Tazobactam in DUPLEX Drug Delivery System
Piperacillin and Tazobactam in the DUPLEX Drug Delivery System is a ready-to-activate, two-compartment container that keeps pre-measured medication and diluent separate until the provider is ready to administer at the bedside by simply folding, squeezing, and shaking to reconstitute.
Global Pharma | 10/04/2025 | By Abha | 804
EssilorLuxottica Announces US Launch of Nuance Audio Glasses
Paving the way for a disruptive new category in the med-tech space, Nuance Audio Glasses are FDA-registered over-the-counter (OTC) hearing aids, allowing consumers to address their hearing needs without requiring a prescription or an audiologist visit. A
Global Pharma | 09/04/2025 | By Manvi | 920
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy